Referred to the House Committee on Energy and Commerce.
The bill amends Section 801(a) of the Federal Food, Drug, and Cosmetic Act to add tobacco products (including “counterfeit tobacco product” as defined elsewhere) alongside drugs and devices in the statutory language that governs denial of entry and disposition of adulterated, misbranded, or counterfeit items offered for import. In effect, it authorizes the Secretary of Health and Human Services to treat tobacco products offered for import the same way the statute currently treats drugs and devices — including destruction when they are adulterated, misbranded, or counterfeit.
Public-health/pro-consumer protection rationale (liberal/centrist) versus federal-overreach and property/due-process concerns (conservative).
Relative to its intended legislative type, this bill is a narrowly focused statutory amendment that is clearly integrated into the Federal Food, Drug, and Cosmetic Act to extend destruction authority to adulterated, misbranded, or counterfeit tobacco products offered for import.
The bill amends Section 801(a) of the Federal Food, Drug, and Cosmetic Act to add tobacco products (including “counterfeit tobacco product” as defined elsewhere) alongside drugs and devices in the statutory language that governs denial of entry and disposition of adulterated, misbranded, or counterfeit items offered for import.
In effect, it authorizes the Secretary of Health and Human Services to treat tobacco products offered for import the same way the statute currently treats drugs and devices — including destruction when they are adulterated, misbranded, or counterfeit.
The statutory change goes into effect on the date of enactment.
Based solely on the bill text, this is a narrow, administratively focused statutory clarification that does not create a large fiscal obligation or a sweeping policy change — characteristics that favor enactment. The lack of substantive controversy in the operative language and the straightforward implementability increase its chances. Offsetting factors include possible sensitivity to the bill title's reference to a foreign country, any stakeholder objections about destruction procedures or trade implications, and routine Senate procedural friction.
Relative to its intended legislative type, this bill is a narrowly focused statutory amendment that is clearly integrated into the Federal Food, Drug, and Cosmetic Act to extend destruction authority to adulterated, misbranded, or counterfeit tobacco products offered for import.
Public-health/pro-consumer protection rationale (liberal/centrist) versus federal-overreach and property/due-process concerns (conservative).
These are examples from the analysis, not a ranked list of the most-affected groups.
Public-health/pro-consumer protection rationale (liberal/centrist) versus federal-overreach and property/due-process concerns (conservative).
A mainstream liberal would likely view this as a public-health–oriented technical fix that closes a gap allowing HHS to remove and destroy harmful or counterfeit tobacco products at the border.
They would note the public-health benefit of keeping adulterated or counterfeit tobacco out of circulation and see this as consistent with stronger tobacco regulation.
However, they could be wary of the bill’s title referencing China, which could encourage stigmatizing rhetoric or geopolitical targeting, and would want safeguards on environmental disposal and transparency.
A centrist/moderate would see this as a narrowly targeted, technical statutory correction that aligns tobacco with existing controls over adulterated or counterfeit drugs and devices.
They would appreciate the public-safety rationale and the bill’s relatively narrow scope.
Their concerns would center on implementation details: cost, interagency roles, environmental compliance, and potential international trade or diplomatic implications.
A mainstream conservative would be cautious about expanding federal authority to destroy imported property, concerned about potential federal overreach, property-rights and due-process implications, and added regulatory burdens.
They would also question whether HHS is the proper agency to run destruction operations (customs or commerce agency might be more appropriate) and worry about costs and bureaucratic expansion.
If the measure appears limited, narrowly focused on truly unsafe or counterfeit goods, and contains clear procedural protections, some conservatives might accept it; otherwise they would be skeptical.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Based solely on the bill text, this is a narrow, administratively focused statutory clarification that does not create a large fiscal obligation or a sweeping policy change — characteristics that favor enactment. The lack of substantive controversy in the operative language and the straightforward implementability increase its chances. Offsetting factors include possible sensitivity to the bill title's reference to a foreign country, any stakeholder objections about destruction procedures or trade implications, and routine Senate procedural friction.
The bill has not accumulated any surfaced votes yet.
Public-health/pro-consumer protection rationale (liberal/centrist) versus federal-overreach and property/due-process concerns (conservative…
Based solely on the bill text, this is a narrow, administratively focused statutory clarification that does not create a large fiscal oblig…
Relative to its intended legislative type, this bill is a narrowly focused statutory amendment that is clearly integrated into the Federal Food, Drug, and Cosmetic Act to extend destruction authority to adulterated, mis…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.